Revenue
26.3 million EUR
2021 · EUR
Exact inputs and evidence
- Revenue: 26306000 EUR Source
Fundies. English
OSE Immunotherapeutics
ESEF2 filing records in this dataset, filed from 2022-04-21 to 2025-05-07. Reported financial figures are available; chart coverage varies by period.
Latest fiscal year
- Cash and cash equivalents
- 16.7 million EUR Source
Exact value
16745000 EUR
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2025-05-07.
Financial data available through: 2024-12-31.
Coverage by financial measure
- Revenue: 2 of 11 periods available· newest 2021-12-31
- Operating income: 4 of 11 periods available· newest 2024-12-31
- Net income: 2 of 11 periods available· newest 2021-12-31
- Operating cash flow: 4 of 11 periods available· newest 2024-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 4 of 11 periods available· newest 2024-12-31
- liabilities: No compatible figures in this window
- Current assets: 4 of 11 periods available· newest 2024-12-31
- Current liabilities: 4 of 11 periods available· newest 2024-12-31
- Cash and cash equivalents: 4 of 11 periods available· newest 2024-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Operating cash flow
+EUR 68.2 millionPrior period
−EUR 19.76 million
–
Current period
EUR 48.44 million
–
Exact inputs and evidence
48440000 − -19764000 = 68204000 EUR
-19764000 EUR · 2023-01-01 – 2023-12-31
Inspect prior input Prior source48440000 EUR · 2024-01-01 – 2024-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Net income, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2021 2021-01-01 – 2021-12-31
- Revenue EUR 26.31 million 100% of revenue
- Operating costs Derived EUR 42.93 million 163% of revenue
- Operating income −EUR 16.63 million −63% of revenue
- Tax, interest and other Derived EUR 225,000 0.9% of revenue
- Net income −EUR 16.85 million −64% of revenue
Cash
- Operating cash flow −EUR 9.92 million −38% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2020 Operating loss: operating costs were 282% of revenue.
- 2021 Operating loss: operating costs were 163% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | 10432000 | 29421000 Derived | -18989000 | -2434000 Derived | -16555000 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 26306000 | 42931000 Derived | -16625000 | 225000 Derived | -16850000 | Unavailable | Source
|
Amounts are exact, in EUR.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
EUR 26.3M 2021
Values and sources
| Period | Series | Value(EUR) | Source evidence |
|---|---|---|---|
| 2020 | Revenue | 10432000 |
|
| 2021 | Revenue | 26306000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
152.2% 2021
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | 152.2% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -63.2% 2021
Net margin -64.1% 2021
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Operating margin | -182% |
|
| 2021 | Operating margin | -63.2% |
|
| 2020 | Net margin | -158.7% |
|
| 2021 | Net margin | -64.1% |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
EUR -9.9M 2021
Values and sources
| Period | Series | Value(EUR) | Source evidence |
|---|---|---|---|
| 2020 | Operating cash flow | -19550000 |
|
| 2021 | Operating cash flow | -9919000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(EUR) | Source evidence |
|---|---|---|---|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020-12-31 | Liabilities / assets | Not reported |
|
| 2021-12-31 | Liabilities / assets | Not reported |
|
Current assets to current liabilities
Current assets divided by current liabilities.
2.64× 2021
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Current assets / current liabilities | 2.82× |
|
| 2021 | Current assets / current liabilities | 2.64× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | −EUR 16.56 million Exact valueExact value: -16555000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 19.55 million Exact valueExact value: -19550000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −EUR 16.85 million Exact valueExact value: -16850000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 9.92 million Exact valueExact value: -9919000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | Unavailable Not reported for this period. | −EUR 19.76 million Exact valueExact value: -19764000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | Unavailable Not reported for this period. | EUR 48.44 million Exact valueExact value: 48440000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
2 filings · 195 latest values · 195 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 969500HIUWVGY6NZSM05, esef:969500HIUWVGY6NZSM05